Cigna Corp (CI · NYSE)

CI · MARKET VIEW

Market view · as of Oct 12, 2026

Revenue (TTM)
$282.38B
+6.7% YoY
Gross margin
9.1%
EPS (latest q)
$7.78
vs $7.58 est · beat
52-wk position
68.1%
-6.7% vs 52w high · +0.6% 1mo

Price (last ~year)

Cigna has beaten consensus in each of its last four quarters, with Q2 2026 EPS of $7.78 versus an estimated $7.58, and revenue rising 6.7% year over year to $71.67B in the quarter. The stock closed at $282.43, up 4.4% over five days and trading 6.7% below its 52-week high, at 11.68x earnings with an analyst target of $342.29. Leverage stands at 2.5x debt/EBITDA on $31.88B of total debt, though operating cash flow was negative $421.0M in the quarter, leaving free cash flow at negative $718.0M. Recent news includes the launch of the Health Sense platform targeting a 10% reduction in inefficient health spending by 2030 and the planned board retirement of Donna Zarcone effective December 31, 2026.

Valuation

Market cap
$74.63B
P/E
11.68
PEG
0.751
P/B
1.711
P/S
0.264
EV/EBITDA
7.64
Beta
0.298
Analyst target
$342.29

Quality & returns

Gross margin
9.1%
Operating margin
4.0%
Profit margin
2.3%
ROE
16.8%
ROA
4.5%

Price movement

Last
$282.43
1-month
+0.6%
3-month
+0.1%
RSI (14)
60
vs SMA200
+1.8%
52-wk position
68.1% -6.7% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$71.67B$2.68B$1.66B$3.27B
2026-03-31$68.49B$2.36B$1.65B$3.28B
2025-12-31$72.47B$2.15B$1.23B$2.69B
2025-09-30$69.75B$2.58B$1.87B$3.34B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots